Todos Med Ltd (TOMDF)

[JoeForkeyBolo]

The last 13 minutes of the presentation is Q & A from investors. Worth watching. The following questions were asked:

1. Do you feel confident in your team to get the uplisting completed before the lock-up runs out? What's the chance of extending the lock-up if Nasdaq uplisting looks imminent?

2. Financials are late this quarter. What was the delay attributed to, and when do you anticipate they will be released?

3. Is the PCR and cPass scaleable? Why don't we have 6 to 10 of these labs spread across the country? Are we considering a JV with one of the big national labs?

4. There's chatter circulating that people are having trouble getting the cPass test from the Provista Diagnostics lab. Are you aware of this?

5. Are there currently any government programs that will drives sales of the cPass test, and are you aware of any future programs?

6. What does your typical customer look like who is ordering the cPass test?

7. Todos has been active in the press. Do you think there will be more coverage?

8. How soon will Tollovid be rolled out in Europe, Asia and the U.S.?

9. Regarding Tollovis, are you going to be ramping up marketing around it? Is supply chain in order for a mass marketing push?

10. Is Todos close to a partnership?

11. Where are we at with India clinical trials?

12. How is international distribution of traditional testing business going? What do you see is the most important part or partner necessary to ramp that up now?